Similar to the free movement of goods and services, the European Commission wants to expand the European Research area in which researchers and innovators can move around in the EU without encountering legal, technological or physical borders. The primary objective is thus to stimulate the mobility of people active in R&I and diffuse the available knowledge all over Europe.
margot.beereboom@fwo.be
+32 2 550 15 76
During the new programme period, the European Research Area (ERA) will support a new phase in the development of the ERA and synergies with the European Higher Education Area, which may include a stronger focus on supporting the challenges identified in Pillar II, including missions and partnerships, to ensure that the strategic investments made there deliver maximum impact.
Opening the European Research Area to future challenges requires developing synergies with the European Higher Education Area in a complex landscape of universities and research organisations with a view to underpinning open science, innovative entrepreneurial practices, life-long-learning and upskilling talent and breaking down disciplinary and inter-sectoral barriers to match emerging business and societal needs.
Impacts will include better alignment of national reforms and increased programme level collaboration across Member States and Associated Countries, and will help increase the impact of both national and European investments in research and innovation. This will also support other research and innovation priorities including Open Science, citizens’ science, gender equality and other forms of diversity, improving international cooperation, ethics and integrity, and scientific input to other EU policies.
Enhancing EU R&I Horizon Europe
The Communication ‘Implementation of the European Research Area (ERA): Strengthening Europe’s Research and Innovation: The ERA’s Journey and Future Directions’ has been adopted on 22 October by the Commission. The Communication takes stock and assesses the progress made since the previous Communication ‘A new ERA for... read more
Enhancing EU R&I Horizon Europe
The EU Award for Gender Equality Champions was created under Horizon Europe to recognise the results achieved by academic and research organisations in the implementation of gender equality plans (GEPs). GEPs is an eligibility criterion for all public bodies, higher education institutions and research organisations from EU Member States and associa... read more
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.